KCNA3 and acute lymphoblastic leukemia: In line with reports underscoring the importance of Kv1.3 channels in survival of leukemic B cells [28, 55] and various cancer cell lines [54], our data provide initial evidence that Kv1.3 channels are druggable targets in chemotherapy of T-ALL and AML.